MRI in active surveillance: a critical review
- 16 August 2018
- journal article
- review article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 22 (1) , 5-15
Abstract
Recent technological advancements and the introduction of modern anatomical and functional sequences have led to a growing role for multiparametric magnetic resonance imaging (mpMRI) in the detection, risk assessment and monitoring of early prostate cancer. This includes men who have been diagnosed with lower-risk prostate cancer and are looking at the option of active surveillance (AS). The purpose of this paper is to review the recent evidence supporting the use of mpMRI at different time points in AS, as well as to discuss some of its potential pitfalls. A combination of electronic and manual searching methods were used to identify recent, important papers investigating the role of mpMRI in AS. The high negative predictive value of mpMRI can be exploited for the selection of AS candidates. In addition, mpMRI can be efficiently used to detect higher risk disease in patients already on surveillance. Although there is an ongoing debate regarding the precise nature of its optimal implementation, mpMRI is a promising risk stratification tool and should be considered for men on AS.Keywords
This publication has 60 references indexed in Scilit:
- Accuracy of Multiparametric MRI for Prostate Cancer Detection: A Meta-AnalysisAmerican Journal of Roentgenology, 2014
- Medium-term Outcomes of Active Surveillance for Localised Prostate CancerEuropean Urology, 2013
- Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancerCancer, 2013
- Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?American Journal of Surgical Pathology, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillanceBritish Journal of Radiology, 2011
- Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy schemeBJU International, 2010
- Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005JNCI: Journal of the National Cancer Institute, 2009
- Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per MilliliterNew England Journal of Medicine, 2004
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998